KBC Group
ALPN

KBC Group’s Alpine Immune Sciences Inc ALPN Stock Holding History

KBC Group’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,107
Closed -$44K – 1928
2024
Q1 		$44K Buy
+1,107
New +$32.7K ﹤0.01% 1628

KBC Group's ALPN Position: Q2 2024 in Review

KBC Group sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 1,107 shares — an estimated $44K sold.

KBC Group first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $44K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • KBC Group reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • KBC Group sold 1,107 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $44K.
  • KBC Group first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
  • KBC Group's Alpine Immune Sciences Inc position peaked at $44K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on KBC Group's 13F filing for Q2 2024, filed 17 Jul 2024.